Zurich Cantonal Bank
PMVP icon

Zurich Cantonal Bank’s PMV Pharmaceuticals PMVP Stock Holding History

Zurich Cantonal Bank’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,443
Closed -$30.7K – 2841
2023
Q1 		$30.7K Buy
6,443
+4,421
+219% +$31.1K ﹤0.01% 2697
2022
Q4 		$17.6K Hold
2,022
– – ﹤0.01% 2766
2022
Q3 		$24K Hold
2,022
– – ﹤0.01% 2769
2022
Q2 		$29K Hold
2,022
– – ﹤0.01% 2734
2022
Q1 		$42K Hold
2,022
– – ﹤0.01% 2562
2021
Q4 		$47K Buy
+2,022
New +$48.9K ﹤0.01% 2762

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Zurich Cantonal Bank's PMVP Position: Q2 2023 in Review

Zurich Cantonal Bank sold out of PMV Pharmaceuticals (PMVP) in Q2 2023, closing a stake of 6,443 shares — an estimated $30.7K sold.

Zurich Cantonal Bank first reported a position in PMVP in Q4 2021 and held it in 6 quarters. The position peaked at $47K in Q4 2021. 106 funds tracked by Wall St. Rank hold PMVP as of Q2 2023.

  • Zurich Cantonal Bank reported no remaining PMV Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Zurich Cantonal Bank sold 6,443 PMV Pharmaceuticals shares in Q2 2023, an estimated $30.7K.
  • Zurich Cantonal Bank first reported a position in PMV Pharmaceuticals in Q4 2021 and held it in 6 quarters.
  • Zurich Cantonal Bank's PMV Pharmaceuticals position peaked at $47K in Q4 2021.
  • 106 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2023.

Based on Zurich Cantonal Bank's 13F filing for Q2 2023, filed 7 Aug 2023.